ClinicalTrials.Veeva

Menu
D

Doherty Clinical Trials | East Melbourne, Australia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

DT-216P2

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia

The purpose of this study is to evaluate the safety and tolerability, and pharmacokinetics of DT-216P2 administered multiple ascending doses in patie...

Enrolling
Friedreich Ataxia
Drug: DT-216P2

Study SP-1219-007 is a multi-centre, randomised, study designed to access the safety and tolerability of two doses of monovalent Influenza A (H7N9) v...

Active, not recruiting
H7N9 Influenza
Combination Product: Adjuvanted Influenza A (H7N9) Monovalent Vaccine Microarray Patch Delivery System (low dose HA, high dose adjuvant)
Combination Product: Adjuvanted Influenza A (H7N9) Monovalent Vaccine Microarray Patch Delivery System (high dose HA, high dose adjuvant)

Trial sponsors

D
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems